Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04601103 · ClinicalTrials.gov registry record · NA
3M Oral Rinse Incidence and Patient Acceptance of Sloughing When Used With Sodium Lauryl Sulfate (SLS) Toothpastes
A NA study, sponsored by Solventum US.
- Terminated
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT04601103: Clinical Trial NA study, sponsored by Solventum US.
NCT04601103 is a NA study that was terminated before completion, run by Solventum US. The registered enrollment target is 53 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04601103, a NA study, was terminated before completion, sponsored by Solventum US.
- TERMINATED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the incidence of oral tissue sloughing through self-report by study subjects and by professional dental examinations.
Primary Outcome
Percentage of participants who experienced oral sloughing as reported either by the subject or determined by the dental evaluator.
Interventions
- DRUG No SLS toothpaste
- DRUG Medium SLS toothpaste
- DRUG High SLS toothpaste
- DEVICE Anti-plaque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2020-01-06 |
| Est. Completion | 2020-03-10 |
| Phase | NA |
Why NCT04601103 stopped before completion
NCT04601103 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 4 interventions - of which No SLS toothpaste is the first listed.
NCT04601103 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04601103 about?
NCT04601103 is a clinical study titled "3M Oral Rinse Incidence and Patient Acceptance of Sloughing When Used With Sodium Lauryl Sulfate (SLS) Toothpastes". The primary objective of this study is to evaluate the incidence of oral tissue sloughing through self-report by study subjects and by professional dental examinations.
What is the current status of trial NCT04601103?
This trial is currently terminated. It is a NA study. The enrollment target is 53 participants. The study started on 2020-01-06. Estimated completion is 2020-03-10.
What interventions are being tested in trial NCT04601103?
The interventions under investigation include: No SLS toothpaste (DRUG), Medium SLS toothpaste (DRUG), High SLS toothpaste (DRUG), Anti-plaque (DEVICE).
Who is sponsoring clinical trial NCT04601103?
This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04601103's enrollment target sits among peer trials
53 1271st of 2000 higher than 729 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI